Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
GSK-3 Inhibitor Elraglusib Enhances Tumor-Infiltrating Immune Cell Activation in Tumor Biopsies and Synergizes with Anti-PD-L1 in a Murine Model of Colorectal Cancer.
Huntington KE, Louie AD, Srinivasan PR, Schorl C, Lu S, Silverberg D, Newhouse D, Wu Z, Zhou L, Borden BA, Giles FJ, Dooner M, Carneiro BA, El-Deiry WS. Huntington KE, et al. Among authors: borden ba. Int J Mol Sci. 2023 Jun 29;24(13):10870. doi: 10.3390/ijms241310870. Int J Mol Sci. 2023. PMID: 37446056 Free PMC article.
Phase I Study of Elraglusib (9-ING-41), a Glycogen Synthase Kinase-3β Inhibitor, as Monotherapy or Combined with Chemotherapy in Patients with Advanced Malignancies.
Carneiro BA, Cavalcante L, Mahalingam D, Saeed A, Safran H, Ma WW, Coveler AL, Powell S, Bastos B, Davis E, Sahai V, Mikrut W, Longstreth J, Smith S, Weisskittel T, Li H, Borden BA, Harvey RD, Sahebjam S, Cervantes A, Koukol A, Mazar AP, Steeghs N, Kurzrock R, Giles FJ, Munster P. Carneiro BA, et al. Among authors: borden ba. Clin Cancer Res. 2024 Feb 1;30(3):522-531. doi: 10.1158/1078-0432.CCR-23-1916. Clin Cancer Res. 2024. PMID: 37982822 Clinical Trial.
Impact of medical school responses during the COVID-19 pandemic on student satisfaction: a nationwide survey of US medical students.
Kim IE Jr, Kim DD, Kim JE, Rebello E, Chung D, Woolley P, Lee D, Borden BA, Wang A, Villalta D, Sutherland A, De Armas S, Liu M, Kim H, Ahn GS, Geisler R, Yang A, Joung B, Slate-Romano J, Rajski M, Kim AE, Vrees R, Monteiro K. Kim IE Jr, et al. Among authors: borden ba. Korean J Med Educ. 2022 Jun;34(2):167-174. doi: 10.3946/kjme.2022.228. Epub 2022 May 31. Korean J Med Educ. 2022. PMID: 35676883 Free PMC article.
Early Detection of Precursor Diseases of Multiple Myeloma.
O'Donnell EK, Borden BA, Ghobrial IM. O'Donnell EK, et al. Among authors: borden ba. Hematol Oncol Clin North Am. 2024 May 9:S0889-8588(24)00030-3. doi: 10.1016/j.hoc.2024.03.003. Online ahead of print. Hematol Oncol Clin North Am. 2024. PMID: 38724285 Review.
GSK-3 inhibitor elraglusib enhances tumor-infiltrating immune cell activation in tumor biopsies and synergizes with anti-PD-L1 in a murine model of colorectal cancer.
Huntington KE, Louie AD, Srinivasan PR, Schorl C, Lu S, Silverberg D, Newhouse D, Wu Z, Zhou L, Borden BA, Giles FJ, Dooner M, Carneiro BA, El-Deiry WS. Huntington KE, et al. Among authors: borden ba. bioRxiv [Preprint]. 2023 Feb 7:2023.02.07.527499. doi: 10.1101/2023.02.07.527499. bioRxiv. 2023. PMID: 36798357 Free PMC article. Updated. Preprint.
The Landscape of Glycogen Synthase Kinase-3 Beta Genomic Alterations in Cancer.
Borden BA, Baca Y, Xiu J, Tavora F, Winer I, Weinberg BA, Vanderwalde AM, Darabi S, Korn WM, Mazar AP, Giles FJ, Crawford L, Safran H, El-Deiry WS, Carneiro BA. Borden BA, et al. Mol Cancer Ther. 2021 Jan;20(1):183-190. doi: 10.1158/1535-7163.MCT-20-0497. Epub 2020 Oct 21. Mol Cancer Ther. 2021. PMID: 33087512
Pharmacogenomic-Based Decision Support to Predict Adherence to Medications.
Christian C, Borden BA, Danahey K, Yeo KJ, van Wijk XMR, Ratain MJ, O'Donnell PH. Christian C, et al. Among authors: borden ba. Clin Pharmacol Ther. 2020 Aug;108(2):368-376. doi: 10.1002/cpt.1838. Epub 2020 May 25. Clin Pharmacol Ther. 2020. PMID: 32236960 Free PMC article.
19 results